Search the Newsreel

Rocket Lab-built satellites for MDA Space begin operations in orbit

[America at night viewed from space with city lights showing activity in United States. 3d render of planet Earth. Elements from NASA. Technology, global communication, world. USA.] NicoElNino/iStock via Getty Images Rocket Lab (RKLB [https://seekingalpha.com/symbol/RKLB]) on Sunday said eight satellite platforms it built for …

Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services

Rocket Lab Corporation Rocket Lab Lightning BusRocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services LONG BEACH, Calif., Aug. 16, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space …

MDA SPACE SATELLITES FOR GLOBALSTAR SUCCESSFULLY LAUNCHED

First set of eight satellites for Globalstar 2-R mission deployed to low Earth orbit on a SpaceX Falcon 9 rocket, marking the beginning of the commissioning phase TORONTO, Aug. 16, 2026 /CNW/ -- MDA Space Ltd. (TSX: MDA) (NYSE: MDA), a leading provider of …

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Will Earnings Beat and Major Buybacks Change Pediatrix Medical Group's (MD) Narrative

Pediatrix Medical Group (MD) recently reported strong Q2 2026 results, with increased sales and net income, alongside significant share repurchases. These actions, particularly the buybacks, are supporting the company's per-share metrics amidst ongoing challenges like reimbursement and labor costs. The article suggests that while …

Amdocs - AOS - Stock Price & News

This article provides a comprehensive overview of Amdocs (AOS) stock, including its current price, market capitalization, and key financial metrics. It details the company's revenue and EPS growth over several fiscal years, along with quarterly performance and fundamental data. The article also includes general …

NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance

Pediatrix Medical Group (MD) awards 472-share equity grant to director

Pediatrix Medical Group (MD) director Shirley A. Weis was granted 472 restricted shares of common stock on August 12, 2026, under the company's 2008 Incentive Compensation Plan. These shares, valued at $26.50 each, will vest on May 7, 2027, and increase Weis's direct holdings …

MDB Capital Holdings, LLC Class A common Q2 2026 Earnings Call Summary

MDB Capital Holdings is shifting its strategy from a high-volume launch model to a "rifle-shot" approach, focusing on monetizing four core assets due to institutional capital rotating towards mega-cap AI companies. The company plans to streamline operations, seek partnerships for its Public Ventures platform, …

InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates

InspireMD, Inc. (NSPR) reported a Q2 loss of $0.17 per share, outperforming the Zacks Consensus Estimate of a $0.2 loss and representing a 15% earnings surprise. The company's revenues for the quarter were $1.77 million, surpassing estimates by 7.33%, although slightly down from the …

INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More

INSPIREMD (NSPR) is set to release its Q2 2026 earnings on August 17th, with analysts forecasting revenue of $1.41 million and a loss of $0.20 per share. Recent insider trading shows more purchases than sales, while hedge fund activity indicates both increased and decreased …

Pediatrix Medical Group (MD) director receives 472-share restricted stock grant

John M. Starcher Jr., a director at Pediatrix Medical Group (MD), was granted 472 restricted shares of common stock on August 12, 2026. These shares, valued at $26.50 each, are part of the company's incentive compensation plan and will vest on May 7, 2027. …

Pediatrix Medical Group (MD) director awarded 472 restricted shares and reports trust holdings

Pediatrix Medical Group director Thomas McEachin was granted 472 restricted shares of common stock on August 12, 2026, valued at $26.50 per share, under the company's incentive plan. These shares will vest on May 7, 2027. Following this transaction, his direct holdings increased to …

Pediatrix Medical Group (MD) grants 472 restricted shares to director Sansone

Pediatrix Medical Group (MD) director Guy P. Sansone received an equity award of 472 restricted shares on August 12, 2026, priced at $26.50 per share. These shares, granted under the company's Second Amended and Restated 2008 Incentive Compensation Plan, will vest on May 7, …

InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk

InspireMD, Inc. reported increased revenues for the first half of 2026, up 56.3% to $5.17 million, driven by U.S. CGuard Prime sales and international growth, despite a voluntary recall of CGuard Prime impacting quarterly revenue and gross margin. The company posted a significant net …

MDB Capital Holdings (MDBH) Q2 2026 Earnings Call: Leaner Costs and Core Asset Focus

MDB Capital Holdings (MDBH) reported Q2 and first-half 2026 results, announcing a strategy to reduce annual operating expenses to $5 million-$6 million. The company plans to monetize four core assets: Public Ventures, PatentVest, eXoZymes, and Paulex Bio, focusing on value inflection points rather than …

Bleichroeder LP Discloses Investment at MDxHealth SA with 33.2% Stake

Bleichroeder LP has disclosed a 33.2% stake in MDxHealth SA after purchasing 24,229,074 shares in a direct offering for $0.454 per share. This investment gives Bleichroeder significant influence and is subject to a 90-day lock-up period. The firm stated its intent for portfolio purposes …

Bleichroeder (MDXH) reports 31.6M-share, 33.2% holding in MDxHealth

Bleichroeder LP and related parties have reported a 33.2% beneficial ownership in MDxHealth SA, totaling 31,648,563 Ordinary Shares. This significant stake was accumulated for investment purposes, including a recent purchase of over 24 million shares in a registered direct offering at $0.454 per share …

Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build

MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside

MDxHealth SA's average stock price target has been reduced from $2.8 to $2.2 by analysts, with individual forecasts ranging from $1 to $4. This updated target suggests a potential upside of approximately 376% from its recent closing price. The consensus rating for the stock …

NMDC Q1 Results: Profit Sees Muted Growth As Margin Shrinks, Revenue Flat

mDR Limited Details Deployment of Rights Issue Proceeds in Q2 2026

HC Wainwright Analysts Boost Earnings Estimates for LifeMD

HC Wainwright analysts have increased their Q4 2027 earnings per share forecast for LifeMD to $0.17 from $0.15, while maintaining a "Buy" rating and a $9 price target. Despite this, analyst sentiment remains mixed with a "Moderate Buy" consensus rating but several recent downgrades. …

Kamdhenu Ventures Q1 Results: Net loss widens to ₹4.4 crore as revenue falls

Kamdhenu Ventures Q1 Results: Consolidated loss widens to ₹441.34 lakh

Celcomdigi Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

MDU Looks 11.4% Overvalued on GF Value™

MDU Resources Group (NYSE: MDU) appears 11.4% overvalued according to GuruFocus's proprietary GF Value™, trading at $20.29 against an intrinsic value estimate of $18.21. The company recently increased its quarterly dividend and reaffirmed earnings guidance, yet faces challenges with a high Price-to-Sales ratio of …

LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages

LifeMD, Inc. (NASDAQ:LFMD) has received a "Moderate Buy" consensus rating from ten brokerages, with an average 12-month price target of $7.57. Despite this, the company reported a slight miss on quarterly earnings and revenue expectations, posting a loss of $0.16 per share and $47.28 …

MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic De-Risking

MDxHealth SA (MDXH) achieved its largest quarter-over-quarter revenue acceleration in Q2 2026, increasing 14% sequentially, while eliminating a $10.4 million liability. The company strengthened its balance sheet with a $20 million financing and reaffirmed its full-year 2026 revenue guidance of $110 million to $115 …

NMDC Shares Fall 2% in Today's Trade; Board Meeting Scheduled for Q1 FY27 Results

BofA Securities Maintains Camden Property Trust(CPT.US) With Buy Rating, Cuts Target Price to $132

BofA Securities has reiterated its Buy rating for Camden Property Trust (CPT.US) but has adjusted its target price downwards to $132. This indicates continued confidence in the stock's potential while acknowledging a revised valuation.

Kamdhenu Ventures reports consolidated net loss of Rs 4.41 crore in the June 2026 quarter

NMDC Q1 Results Today: Time, Earnings Call, Dividend News, What To Watch, Share Price Performance